Figure 1.
Impact of withanolides in reducing cell viability and proliferation of acute myeloid leukemia (AML) cell models. Percentage of viable cells and number of cells relative to control was determined as a function of treatment with withametelin (WTH) (A) or coagulansin A (CoA) (B) in the named cell lines. IC50 was determined using the pharmacoGx package in R.